Zhaoke Ophthalmology appoints PharmaLogic Development Inc. as Regulatory Consultant for Product Development in North America

First Patient Enrolled for the Investigator-Initiated trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Neurotrophic Keratitis

Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2020 China Top 100 Innovative Biotech Companies List”

Podcast Series Episode 4: Glaucoma and Zhaoke Ophthalmology's New Treatments

Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2020 China Top 100 Innovative Biotech Companies List”